Regulation of novel human prolyl 4-hydroxylases
    1.
    发明申请
    Regulation of novel human prolyl 4-hydroxylases 审中-公开
    新型人脯氨酰4-羟化酶的调控

    公开(公告)号:US20060110769A1

    公开(公告)日:2006-05-25

    申请号:US11316907

    申请日:2005-12-27

    IPC分类号: C12Q1/68 C12Q1/30

    摘要: Reagents that regulate human prolyl 4-hydroxylase and reagents which bind to human prolyl 4-hydroxylase gene products can play a role in preventing, ameliorating, or correcting dysfunctions or diseases including, but not limited to cardiovascular disorders, cancer, inflammatory diseases, fibrotic disorders, anemia, and CNS disorders, such as stroke.

    摘要翻译: 调节人脯氨酰4-羟化酶的试剂和与人脯氨酰4-羟化酶基因产物结合的试剂可以在预防,改善或矫正功能障碍或疾病中发挥作用,包括但不限于心血管疾病,癌症,炎性疾病,纤维化疾病 ,贫血和中枢神经系统疾病,如中风。

    Synthetic peptide neutrophil cell chemotactic agents
    4.
    发明授权
    Synthetic peptide neutrophil cell chemotactic agents 失效
    合成肽嗜中性粒细胞趋化剂

    公开(公告)号:US06184342B2

    公开(公告)日:2001-02-06

    申请号:US08330594

    申请日:1994-10-28

    IPC分类号: A61K3800

    CPC分类号: C07K14/705 A61K38/00

    摘要: These compositions are new synthetic peptides and antibodies which are potent chemotactic agents for human neutrophils, and methods for their use. The specificity of these peptides is amino acid sequence specific for binding to a heretofore unidentified receptor on the surface of neutrophils. Neutrophil response to this peptide is specific, since monocytes and fibroblasts do not show any expression of this receptor. Antibodies against these peptides block the chemotactic response. Such antibodies are useful to modulate neutrophil recruitment to a wound site for enhancing or inhibiting inflammation and early effects of wound healing.

    摘要翻译: 这些组合物是用于人嗜中性粒细胞的有效趋化剂的新的合成肽和抗体及其使用的方法。 这些肽的特异性是与嗜中性粒细胞表面上迄今未鉴定的受体结合特异性的氨基酸序列。 对这种肽的嗜中性粒细胞反应是特异性的,因为单核细胞和成纤维细胞不显示该受体的任何表达。 针对这些肽的抗体阻断趋化反应。 这样的抗体可用于调节嗜中性粒细胞募集到伤口部位以增强或抑制炎症和伤口愈合的早期作用。

    Synthetic peptide neutrophil cell chemotactic agents
    7.
    发明申请
    Synthetic peptide neutrophil cell chemotactic agents 审中-公开
    合成肽嗜中性粒细胞趋化剂

    公开(公告)号:US20050019331A1

    公开(公告)日:2005-01-27

    申请号:US10718930

    申请日:2003-11-20

    CPC分类号: C07K14/705 A61K38/00

    摘要: These compositions are new synthetic peptides and antibodies which are potent chemotactic agents for human neutrophils, and methods for their use. The specificity of these peptides is amino acid sequence specific for binding to a heretofore unidentified receptor on the surface of neutrophils. Neutrophil response to this peptide is specific, since monocytes and fibroblasts do not show any expression of this receptor. Antibodies against these peptides block the chemotactic response. Such antibodies are useful to modulate neutrophil recruitment to a wound site for enhancing or inhibiting inflammation and early effects of wound healing.

    摘要翻译: 这些组合物是用于人嗜中性粒细胞的有效趋化剂的新的合成肽和抗体及其使用的方法。 这些肽的特异性是与嗜中性粒细胞表面上迄今未鉴定的受体结合特异性的氨基酸序列。 对这种肽的嗜中性粒细胞反应是特异性的,因为单核细胞和成纤维细胞不显示该受体的任何表达。 针对这些肽的抗体阻断趋化反应。 这样的抗体可用于调节嗜中性粒细胞募集到伤口部位以增强或抑制炎症和伤口愈合的早期作用。

    Regulation of human transketolase-like enzyme
    9.
    发明申请
    Regulation of human transketolase-like enzyme 审中-公开
    人类转酮酶样酶的调节

    公开(公告)号:US20050214908A1

    公开(公告)日:2005-09-29

    申请号:US11117441

    申请日:2005-04-29

    摘要: Reagents which regulate human transketolase-like enzyme and reagents which bind to human transketolase-like enzyme gene products can play a role in preventing, ameliorating, or correcting dysfunctions or diseases including but not limited to, cancer, anemia, and end-stage renal disease, including sensory periphery neuropathy associated with uremia.

    摘要翻译: 调节人类转酮醇酶样酶的试剂和与人类转酮酶样酶基因产物结合的试剂可以在预防,改善或矫正功能障碍或疾病中发挥作用,包括但不限于癌症,贫血和终末期肾病 ,包括与尿毒症相关的感觉性周围神经病变。